COVID vaccine indemnity threshold reduced The change will enable more people to access compensation for vaccine injury, according to the Federal Health Minister.
TGA updates post-COVID vaccine myocarditis rates As many of Australia’s remaining vaccine-hesitant patients express concerns over rare side effects associated with mRNA vaccines, the TGA has broken down rates of myocarditis cases following Pfizer doses.
Processing for COVID-19 vaccine compensation scheme to begin next month Around 10,000 potential claims related to adverse reactions have been registered since September.
UK study shows surging efficacy after COVID-19 booster The country’s first real-world study since its booster program began shows it is having a significant impact on protection for over-50s.
New treatment could offer 18 months protection against severe COVID The monoclonal antibody treatment, AZD7442, recently completed phase 3 clinical trials.
New insight into vaccines’ protection against Delta deaths AstraZeneca and Pfizer offer at least 90% protection from death caused by the Delta variant of the SARS-CoV-2 virus, new international analysis suggests.
‘Absolutely heartbreaking’: GP forced to throw out hundreds of expired COVID vaccines Plans have been announced to send unused doses overseas, but an absence of forward planning is resulting in wastage.
COVID-19 vaccination reduces household transmission up to 97% The new research findings also appear to be reflected by the recent downward trend in Australian locally acquired cases, a former World Health Organization epidemiologist says.
TGA monitoring overseas Moderna recommendations Several countries have limited the use of the mRNA vaccine in younger people, but there is no sign Australia will institute a similar pause.
Adolescents at most risk of developing myocarditis: TGA Myocarditis rates related to the Pfizer vaccine been released, while the Moderna vaccine has been included in the safety report for the first time.